IRIDEX is an ophthalmic medical technology company focused on the development and commercialization of products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Certain of Co.'s laser products are powered by its proprietary MicroPulse technology. Co. provides three product categories: laser consoles; delivery devices which are optical-mechanical products that mount to ophthalmologist's diagnostic equipment and transmit the laser; and single-use disposable probes that transmit the laser light to a targeted region within the inside of an eye. The IRIX stock yearly return is shown above.
The yearly return on the IRIX stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2020 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the IRIX annual return calculation with any dividends reinvested as applicable (on ex-dates).
|